Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hematide in non-dialysis chronic renal failure patients with anemia
jRCT2080221165Phase 3
- Sponsor
- Takeda
- Start
- Jul 2010
- Modality
- Peptides, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of peginesatide in anaemia and chronic kidney disease (CKD), sponsored by Takeda.
02
Drugs
peginesatide
03
Conditions
anaemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080221165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221165.